| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
1993-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c80ec7b8cb29758d4cb92cdbb25039b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88e4f40a60e725d63036235ddd2d75d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d4032df4c207d9df7fc8e6e0b71f7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c777bf31c1b8aa2bf8a6bd57f411477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23509cd292c502b36e45abbd33e2aa70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fd9626bb152bfc0dc1c45701bb8002a |
| publicationDate |
1998-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2116300-C1 |
| titleOfInvention |
Imidazole derivatives or their physiologically acceptable salts, method of their synthesis, agent for blood hypertension decrease and pharmaceutical composition for blood pressure decrease |
| abstract |
FIELD: organic chemistry. SUBSTANCE: invention relates to the synthesis of imidazole derivatives containing biphenylsulphonylurea or biphenylsulphonylurethan side-chain of the formula (I): <EMI ID=0.199 HE=48 WI=36 TI=CHI> where R - ethyl; R - methyl; N - O; R - COOH and R - SO<CHF>-@2</CHF>-NH-CO-NH-CH<SB>3</SB>. These compounds are high-active antagonists of angiotensin-II-receptors. EFFECT: improved method of synthesis, enhanced effectiveness of compounds synthesized. 7 cl, 1 tbl, 10 ex |
| priorityDate |
1992-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |